宿主細胞汚染物質は、免疫原性を引き起こし、薬物の安定性や有効性を低下させ、患者の安全を危険にさらす可能性のある宿主細胞に見られるタンパク質です。宿主細胞タンパク質は、酵母、大腸菌、哺乳類などの組換え治療用タンパク質を生成する宿主生物によってコード化されたタンパク質です。バイオ医薬品の製造中、宿主細胞の不純物はバイオ医薬品の精製における重要なステップです。バイオ医薬品開発の最も困難な側面の1つは、宿主細胞タンパク質の除去です。それは薬剤の安全性と有効性のいずれにも影響を与える能力があります。バイオ医薬品の進歩や個別化医療の需要の高まりなどの要因が、世界の宿主細胞汚染物質検査市場を牽引しています。
宿主細胞汚染物質検査に投資している企業は、パートナーシップ契約を結んでいます。たとえば、2021年6月、ライフサイエンス研究および臨床診断製品の世界的リーダーであるBio-Rad Laboratories、Inc。（米国）は、多重分子診断の世界的リーダーであるSeegene、Inc。（韓国）とのパートナーシップを発表しました。2019年6月、MaravaiLifeSciencesの支配下にあるCygnusTechnologies（米国）は、宿主細胞タンパク質（HCP）分析のサービス事業の拡大を発表しました。検出ツールにおけるパイオニアCygnusは、治療の有効性と安定性に影響を与える可能性のあるバイオ医薬品やワクチン中のHCP不純物を発見して定量化するサービスも提供しています。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Product
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on Supply Chain
5.3.3. Regional Impact
5.3.4. Opportunity and Threat Analysis
6. GLOBAL HOST CELL CONTAMINANT TESTING MARKET, BY TYPE
6.1. Overview
6.2. 1.Host Cell Protein Assay
6.2.1. ELISA
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
6.2.2. ILA
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
6.2.3. SDS-PAGE
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
6.2.4. Immunoblotting
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
6.3. 2.Host Cell DNA Assay
6.3.1. Quantitative PCR
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
6.3.2. Dot-Blot Hybridization
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
7. GLOBAL HOST CELL CONTAMINANT TESTING MARKET, BY END USER
7.1. Overview
7.2. Biopharmaceutical Companies
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
7.3. . Contract Research Organizations
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
7.4. Contract Manufacturing Organizations
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
7.5. Academic & Research Institutes
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
8. GLOBAL HOST CELL CONTAMINANT TESTING MARKET, BY REGION
8.1. Overview
8.2. North America
8.2.1. US
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. Italy
8.3.4. Spain
8.3.5. UK
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. Rest of Asia-Pacific
8.5. Middle East & Africa
8.5.1. Middle East
8.5.2. Africa
8.5.3. Latin America
9. COMPANY LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Host Cell Contaminant Testing Market
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Host Cell Contaminant Testing Market
9.7. Key Developments and Growth Strategies
9.7.1. New ProductLaunch/Service Deployment
9.7.2. Merger & Acquisition
9.7.3. Joint Venture
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2020
9.8.2. Major Players R&D Expenditure, 2020
10. COMPANY PROFILES
10.1. BioGenes GmbH
10.1.1. Company Overview
10.1.2. Products Offered
10.1.3. Financial Overview
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Bio-Rad Laboratories, Inc.
10.2.1. Company Overview
10.2.2. Products Offered
10.2.3. Financial Overview
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Cisbio Bioassays SAS
10.3.1. Company Overview
10.3.2. Products Offered
10.3.3. Financial Overview
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Cisbio Bioassays SAS
10.4.1. Company Overview
10.4.2. Products Offered
10.4.3. Financial Overview
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Cygnus Technologies LLC
10.5.1. Company Overview
10.5.2. Products Offered
10.5.3. Financial Overview
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Enzo Life Sciences, Inc.
10.6.1. Company Overview
10.6.2. Products Offered
10.6.3. Financial Overview
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. ForteBio
10.7.1. Company Overview
10.7.2. Products Offered
10.7.3. Financial Overview
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. GE Healthcare
10.8.1. Company Overview
10.8.2. Products Offered
10.8.3. Financial Overview
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Molecular Devices LLC
10.9.1. Company Overview
10.9.2. Products Offered
10.9.3. Financial Overview
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. ProteinSimple
10.10.1. Company Overview
10.10.2. Products Offered
10.10.3. Financial Overview
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. Thermo Fisher Scientific, Inc.
10.11.1. Company Overview
10.11.2. Products Offered
10.11.3. Financial Overview
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
?
LIST OF TABLES
TABLE 1 GLOBAL HOST CELL CONTAMINANT TESTING MARKET SYNOPSIS, 2018-2027
TABLE 2 GLOBAL HOST CELL CONTAMINANT TESTING MARKET ESTIMATES & FORECAST, 2018-2027 (USD MILLION)
TABLE 3 GLOBAL HOST CELL CONTAMINANT TESTING MARKET, BYTYPE, 2018-2027 (USD MILLION)
TABLE 4 GLOBAL HOST CELL CONTAMINANT TESTING MARKET, BY END USER,2018-2027 (USD MILLION)
TABLE 5 NORTH AMERICA HOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 6 NORTH AMERICA HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 7 US HOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 8 US HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 9 CANADA HOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 10 CANADA HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 11 EUROPE HOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 12 EUROPE HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 13 GERMANY HOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 14 GERMANY HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 15 UKHOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 16 UK: HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 17 FRANCEHOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 18 FRANCE HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 19 ITALYHOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 20 ITALYHOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 21 SPAINHOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 22 SPAIN HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 23 REST OF EUROPE HOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 24 REST OF EUROPE HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 25 ASIA-PACIFIC HOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 26 ASIA-PACIFIC HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 27 INDIAHOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 28 INDIAHOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 29 CHINA HOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 30 CHINA HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 31 JAPAN HOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 32 JAPAN HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 33 SOUTH KOREAHOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 34 SOUTH KOREA HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 35 AUSTRALIA HOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 36 AUSTRALIA HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 37 REST OF ASIA-PACIFIC HOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 38 REST OF ASIA-PACIFIC HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 39 REST OF THE WORLD HOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 40 REST OF THE WORLD HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 41 MIDDLE EASTHOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 42 MIDDLE EAST HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 43 AFRICAHOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 44 AFRICA HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 45 LATIN AMERICA HOST CELL CONTAMINANT TESTING MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 46 LATIN AMERICA HOST CELL CONTAMINANT TESTING MARKET, BY END USER, 2018-2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL HOST CELL CONTAMINANT TESTING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL HOST CELL CONTAMINANT TESTING MARKET
FIGURE 4 GLOBAL HOST CELL CONTAMINANT TESTING MARKET SHARE, BY TYPE, 2020 (%)
FIGURE 5 GLOBAL HOST CELL CONTAMINANT TESTING MARKET SHARE, BY END USER, 2020 (%)
FIGURE 6 GLOBAL HOST CELL CONTAMINANT TESTING MARKET SHARE, BY REGION, 2020 (%)
FIGURE 7 NORTH AMERICA HOST CELL CONTAMINANT TESTING MARKET SHARE, BY REGION, 2020 (%)
FIGURE 8 EUROPE HOST CELL CONTAMINANT TESTING MARKET SHARE, BY REGION, 2020 (%)
FIGURE 9 ASIA-PACIFIC HOST CELL CONTAMINANT TESTING MARKET SHARE, BY REGION, 2020 (%)
FIGURE 10 REST OF THE WORLDHOST CELL CONTAMINANT TESTING MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 GLOBAL HOST CELL CONTAMINANT TESTING MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 12 BIOGENES GMBH:FINANCIAL OVERVIEW
FIGURE 13 BIOGENES GMBH:SWOT ANALYSIS
FIGURE 14 BIO-RAD LABORATORIES, INC.:FINANCIAL OVERVIEW
FIGURE 15 BIO-RAD LABORATORIES, INC.:SWOT ANALYSIS
FIGURE 16 CISBIO BIOASSAYS SAS:FINANCIAL OVERVIEW
FIGURE 17 CISBIO BIOASSAYS SAS:SWOT ANALYSIS
FIGURE 18 CYGNUS TECHNOLOGIES LLC:FINANCIAL OVERVIEW
FIGURE 19 CYGNUS TECHNOLOGIES LLC:SWOT ANALYSIS
FIGURE 20 ENZO LIFE SCIENCES, INC.:FINANCIAL OVERVIEW
FIGURE 21 ENZO LIFE SCIENCES, INC.:SWOT ANALYSIS
FIGURE 22 FORTEBIOFINANCIAL OVERVIEW
FIGURE 23 FORTEBIO:SWOT ANALYSIS
FIGURE 24 GE HEALTHCARE: FINANCIAL OVERVIEW
FIGURE 25 GE HEALTHCARE: SWOT ANALYSIS
FIGURE 26 MOLECULAR DEVICES LLC: FINANCIAL OVERVIEW
FIGURE 27 MOLECULAR DEVICES LLC: SWOT ANALYSIS
FIGURE 28 PROTEINSIMPLE:FINANCIAL OVERVIEW
FIGURE 29 PROTEINSIMPLE:SWOT ANALYSIS
FIGURE 30 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW
FIGURE 31 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
